John T Williams

5PUBLICATIONS
17CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2023
The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection.

John T Williams, Matthew Giletto, Elizabeth R Haiderer

|Aug 23, 2023
Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and in vivo efficacy.

Ifeanyichukwu E Eke, John T Williams, Elizabeth R Haiderer

|Feb 23, 2022
Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus.

Juan Manuel Belardinelli, Deepshikha Verma, Wei Li

|Aug 14, 2019
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.

John T Williams, Elizabeth R Haiderer, Garry B Coulson

Pageof 1